Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics

Spectrum Pharmaceuticals, Inc. (SPPI): $1.58

-0.01 (-0.32%)

POWR Rating

Component Grades













Add SPPI to Watchlist
Sign Up

Industry: Biotech


of 476

in industry

SPPI Stock Summary

  • The ratio of debt to operating expenses for Spectrum Pharmaceuticals Inc is higher than it is for about merely 0.37% of US stocks.
  • With a year-over-year growth in debt of -100%, Spectrum Pharmaceuticals Inc's debt growth rate surpasses only 0% of about US stocks.
  • As for revenue growth, note that SPPI's revenue has grown -72.9% over the past 12 months; that beats the revenue growth of merely 1.74% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Spectrum Pharmaceuticals Inc, a group of peers worth examining would be RMBS, QUIK, XERS, PDFS, and CTIC.
  • SPPI's SEC filings can be seen here. And to visit Spectrum Pharmaceuticals Inc's official web site, go to www.sppirx.com.

SPPI Stock Price Chart Interactive Chart >

Price chart for SPPI

SPPI Price/Volume Stats

Current price $1.58 52-week high $5.24
Prev. close $1.58 52-week low $1.53
Day low $1.53 Volume 2,611,684
Day high $1.63 Avg. volume 2,732,497
50-day MA $2.02 Dividend yield N/A
200-day MA $2.91 Market Cap 258.23M

Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.

SPPI Latest News Stream

Event/Time News Detail
Loading, please wait...

SPPI Latest Social Stream

Loading social stream, please wait...

View Full SPPI Social Stream

Latest SPPI News From Around the Web

Below are the latest news stories about Spectrum Pharmaceuticals Inc that investors may wish to consider to help them evaluate SPPI as an investment opportunity.

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Could Experience -49.26% Growth

In last trading session, Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) saw 2.02 million shares changing hands with its beta currently measuring 1.90. Companys recent per share price level of $2.05 trading at $0.01 or 0.49% at ring of the bell on the day assigns it a market valuation of $368.34M. That closing price of SPPIs stock is Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Could Experience -49.26% Growth Read More »

Marketing Sentinel | November 12, 2021

Spectrum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Spectrum Pharmaceuticals, Inc. in conjunction with their 2021 Q3 earnings call....

SA Transcripts on Seeking Alpha | November 11, 2021

Spectrum Pharmaceuticals, Inc.'s (SPPI) CEO Joseph Turgeon on Q3 2021 Results - Earnings Call Transcript

Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Joseph Turgeon - President and Chief Executive Officer Kurt Gustafson - Executive Vice President and Chief Financial Officer Francois Lebel - Executive Vice President and Chief Medical Officer Conference Call Participants Alethia Young...

SA Transcripts on Seeking Alpha | November 11, 2021

Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference

Business Wire | November 11, 2021

Spectrum Pharmaceuticals, inc (SPPI) Q3 2021 Earnings Call Transcript

Joining me on the call today from Spectrum Pharmaceuticals will be Joe Turgeon, President and CEO; and Dr. Francois Lebel, our Chief Medical Officer. Before we get started, I would like to reference the notice regarding forward-looking statements included in today's press release.

Yahoo | November 11, 2021

Read More 'SPPI' Stories Here

SPPI Price Returns

1-mo -13.66%
3-mo -34.17%
6-mo -58.85%
1-year -66.45%
3-year -89.07%
5-year -61.46%
YTD -53.67%
2020 -6.32%
2019 -58.40%
2018 -53.83%
2017 327.77%
2016 -26.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7477 seconds.